A Second Look: Discussing the 2023 AACR presentation of MCLA-158 (petosemtamab), an IgG1 bispecific antibody targeting EGFR and LGR5, in advanced head and neck squamous cell carcinoma (HNSCC)

Executed on:Jan 29, 2024 12:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: The Institute of Cancer ResearchNIHR Senior Investigator and Head of Division of Radiotherapy at the Institute of Cancer Research
Held 5 CRUK Programme Grants (2 Current) on the topics of head and neck cancer and oncolytic virotherapy
His reserch interests include immunotherapy, targeted radiation sensitisers and oncolytic virotherapy
 

Interview Goal

Discuss the AACR presentation with one of the authors

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.